Kainos Capital, a Dallas-based private equity firm focused on the food and consumer products and services sectors, has closed its Kainos Capital Partners III LP with over $1 billion in capital commitments, the largest investment vehicle in Kainos’ history.
Fund III will primarily target family-owned businesses and corporate carve-outs in the food and consumer products sectors with at least $10 million in Ebitda. The fund can commit in excess of $300 million of equity, and potentially more with the limited partner co-investment program, in any transaction. To date, Fund III is approximately one-third invested across three acquisitions: CellCore Biosciences, a wellness company offering dietary supplements sold through the practitioner channel, Specialty Sales, a dairy cow health distribution business, and Evriholder Products, a provider of impulse products and merchandising services.
“Our bench of seasoned investors and operators within the food and consumer sectors helps drive financial and operational performance by working hand-in-glove with management teams,” comments Andrew Rosen, managing partner of Kainos. “We believe Kainos’ sector experience, industry relationships, and robust operating capabilities make us an attractive partner to families and entrepreneurs who are excited about their business’ prospects yet seek to diversify their wealth.